Photo - Ancora.ai AG
play_arrow
View
49563

Ancora.ai AG

Humanizing clinical trials using AI

Switzerland
Market: Artificial Intelligence
Stage of the project: Prototype or product is ready

Date of last change: 29.09.2020
Rating
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:

Idea

Ancora.ai is an AI-powered platform that supports clinical trials with powerful and patient-friendly technology.

Current Status

We have three customers: 2 Pharma and 1 CRO. We have a CRO, a Pharma, and several hospitals in our pipeline. We have several partnerships also in place (hospital tech company, e-consent company).

Market

We are the technical backbone for the future of remote clinical trials. Trial sites, CROs and Pharma running trials can use Ancora.ai to provide one seamless experience to patients throughout their participation. Value for CROs/Pharma is patient engagement and for hospitals Ancora.ai helps save time and ensure that trials become part of everyday practice for the first time.

Problem or Opportunity

Patients and physicians struggle with participating in clinical research and with the pandemic stoking fire of digitization in healthcare, clinical trials MUST offer more remote and decentralized services to continue. Ancora.ai is the platform that connects patients and clinicians to trials.

Solution (product or service)

www.ancora.ai or https://www.youtube.com/watch?v=lcDaY7LxKaM&t=10s for product demo.

Competitors

Companies in similar space include Antidote, Clara Health, Medable.

Advantages or differentiators

Our AI algorithms are proprietary and have taken 3 years to develop. Off-the-shelf ontologies are not useful in the complex world of clinical trials and when providing a patient-friendly experience. We use NLP as the translator to connect patients to clinical research.

Finance

CRO - subscription/trial
Hospitals / sites: subscription/trial
Patients -users, free
Physicians - users, free
Pharma (subscripton/per trial)

Business model

B2B

Money will be spent on

Key hires. Integration of partner offerings. B2B customer development. Localization in Europe.

Offer for investor

We aim to raise a seed round of 2M USD.

Team or Management

Incubation/Acceleration programs accomplishment

Google Female Founders, EIT Health Headstart, Almirall Digital Garden, Future Perfect, Digital Top 50.

Won the competition and other awards

See above.

Photos

Photo 1 - Humanizing clinical trials using AI

Product Video

5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility83
star0
Add to favorites
Delete from favorites
share
close
thumb_up1
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video